Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 47,461 | 12,500 | 8,634 | 5,940 | 1,037 |
| Cost of Goods | 20,543 | 2,305 | 1,585 | 1,550 | 428 |
| Gross Profit | 26,918 | 10,195 | 7,049 | 4,390 | 609 |
| Operating Expenses | 39,575 | 15,978 | 15,955 | 12,226 | 11,917 |
| Operating Income | -12,657 | -5,783 | -8,906 | -7,836 | -11,308 |
| Interest Expense | 1,014 | N/A | N/A | N/A | 0 |
| Other Income | 36,453 | 35,247 | 30,105 | 31,309 | 48,324 |
| Pre-tax Income | 22,782 | 29,464 | 21,199 | 23,473 | 37,016 |
| Income Tax | 4,749 | 5,385 | 3,955 | 4,913 | 2,849 |
| Net Income Continuous | 18,033 | 24,079 | 17,244 | 18,560 | 34,167 |
| Minority Interests | -3,516 | N/A | N/A | N/A | N/A |
| Net Income | $14,517 | $24,079 | $17,244 | $18,560 | $34,167 |
| EPS Basic Total Ops | 0.10 | 0.17 | 0.12 | 0.15 | 0.36 |
| EPS Basic Continuous Ops | 0.10 | 0.17 | 0.12 | 0.15 | 0.36 |
| EPS Diluted Total Ops | 0.10 | 0.17 | 0.12 | 0.15 | 0.35 |
| EPS Diluted Continuous Ops | 0.10 | 0.17 | 0.12 | 0.15 | 0.35 |
| EBITDA(a) | $28,066 | $-3,851 | $-7,277 | $-7,399 | $37,140 |